Skip to content
Disclosery

EXANE DERIVATIVES: MSCI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on MSCI, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 242 MSCI shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 242 shares
    Change vs previous 13F -413 shares

    0.06% of the 13F portfolio, value $99,720.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 655 shares
    Change vs previous 13F -49 shares

    0.09% of the 13F portfolio, value $329,366.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 704 shares
    Change vs previous 13F +477 shares

    0.1% of the 13F portfolio, value $431,318.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 227 shares
    Change vs previous 13F -106 shares

    0.03% of the 13F portfolio, value $138,088.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 333 shares
    Change vs previous 13F +208 shares

    0.04% of the 13F portfolio, value $185,667.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 125 shares
    Change vs previous 13F 0 shares

    0.02% of the 13F portfolio, value $52,408.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 125 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $55,814.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).